Associate Medical Director, Oncology – Genitourinary Focus

Role Overview

• Partner with the Senior Medical Director, Genitourinary Oncology to develop and execute clinical strategies supporting Natera’s molecular diagnostic tools for GU cancers, including minimal residual disease (MRD) and ctDNA-based monitoring.
• Lead the design and implementation of clinical studies and treatment protocols that integrate Natera’s technology into standard GU oncology care.
• Recruit and engage leading principal investigators (PIs) and clinical sites in GU oncology to participate in company-sponsored studies; manage study timelines and budgets in collaboration with Clinical Trial Operations.
• Advise on product development for the GU oncology portfolio, identifying clinical unmet needs, new product opportunities, key product features, intended use, test report content, and minimum validation requirements.
• Provide post-launch medical affairs support, including interpretation of test results, clinical consultation for healthcare providers, and guidance on patient counseling (pre
• and post-test).
• Serve as GU oncology expert for support of high-value engagement and events identified by Strategic Accounts, Area Sales and Marketing leaders, commercial or clinical leadership.
• Lead medical education initiatives, including external training, launch planning, and the creation of scientific and clinical materials specific to GU malignancies.
• Identify and recruit Key Opinion Leaders (KOLs) in GU oncology to serve on advisory boards and contribute to strategic planning.
• Support the publication strategy by collaborating with Scientific Communications on manuscripts, abstracts, and conference presentations in GU oncology.
• Contribute to regulatory strategy by providing medical input into submissions related to GU cancer diagnostic products.
• Represent Natera’s medical voice externally through public relations, industry panels, advisory boards, and medical conferences, with a focus on GU oncology.

Requirements

• M.D. required (board-certified or board-eligible in Radiation Oncology preferred)
• At least 3 years of post-residency clinical experience in GU cancers (prostate, bladder, kidney, etc.) as a primary treating radiation oncologist
• Deep knowledge of treatment paradigms, clinical guidelines, and diagnostic workflows in GU cancers
• Minimum 3 years of clinical trial experience in academic, biotech, or pharmaceutical settings
• Willingness to travel >40% (primarily U.S.-based, with occasional international travel)

Benefits

• Health insurance
• 401k benefits
• Commuter benefits
• Pregnancy and baby bonding leave
• Free testing for employees and dependents